Article
Clinical value of next-generation sequencing compared to cytogenetics in patients with suspected myelodysplastic syndrome.
British journal of haematology - 1 Feb 2021
Kawata Eri, Lazo-Langner Alejandro, Xenocostas Anargyros, Hsia Cyrus C, Howson-Jan Kang, Deotare Uday, Saini Lalit, Yang Ping, Broadbent Robert, Levy Michael, Howlett Christopher, Stuart Alan, Kerkhof Jennifer, Santos Stephanie, Lin Hanxin, Sadikovic Bekim, Chin-Yee Ian
Abstract excerpt
Next-generation sequencing (NGS) increasingly influences diagnosis, prognosis and management of myelodysplastic syndrome (MDS). In addition to marrow morphology and flow cytometry, our institution performs cytogenetics (CG) and NGS-based testing routinely in patients with suspected MDS. We evaluated the relative value of NGS in the assessment of patients with suspected MDS. We initially compared the diagnostic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.